Compare, Analyse Dr. Reddys with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   TEVA PHARMA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-21
TEVA PHARMA
Dec-13
DR. REDDYS LAB/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs5,5153,125-   
Low Rs3,0282,715-   
Sales per share (Unadj.) Rs1,145.41,793.5-  
Earnings per share (Unadj.) Rs114.5112.0-  
Cash flow per share (Unadj.) Rs188.4257.0-  
Dividends per share (Unadj.) Rs25.0098.08-  
Avg Dividend yield %0.63.4 17.4%  
Book value per share (Unadj.) Rs1,053.21,992.3-  
Shares outstanding (eoy) m166.30848.00-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.71.6 229.1%   
Avg P/E ratio x37.326.1 143.2%  
P/CF ratio (eoy) x22.711.4 199.6%  
Price / Book Value ratio x4.11.5 276.7%  
Dividend payout %21.887.5 24.9%   
Avg Mkt Cap Rs m710,2892,476,101 28.7%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m36,2990-   
Avg. sales/employee Rs ThNM33,839.3-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,113.9-  
INCOME DATA
Net Sales Rs m190,4751,520,909 12.5%  
Other income Rs m2,9140-   
Total revenues Rs m193,3891,520,909 12.7%   
Gross profit Rs m38,699416,502 9.3%  
Depreciation Rs m12,288122,937 10.0%   
Interest Rs m97029,873 3.2%   
Profit before tax Rs m28,355263,692 10.8%   
Minority Interest Rs m01,198 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-173,099 0.0%   
Tax Rs m9,319-3,219 -289.5%   
Profit after tax Rs m19,03695,010 20.0%  
Gross profit margin %20.327.4 74.2%  
Effective tax rate %32.9-1.2 -2,691.9%   
Net profit margin %10.06.2 160.0%  
BALANCE SHEET DATA
Current assets Rs m145,5031,027,216 14.2%   
Current liabilities Rs m81,038895,820 9.0%   
Net working cap to sales %33.88.6 391.7%  
Current ratio x1.81.1 156.6%  
Inventory Days Days6191 67.6%  
Debtors Days Days9596 99.2%  
Net fixed assets Rs m109,979496,762 22.1%   
Share capital Rs m8323,744 22.2%   
"Free" reserves Rs m174,3190-   
Net worth Rs m175,1511,689,442 10.4%   
Long term debt Rs m6,299777,675 0.8%   
Total assets Rs m255,4823,475,765 7.4%  
Interest coverage x30.29.8 307.6%   
Debt to equity ratio x00.5 7.8%  
Sales to assets ratio x0.70.4 170.4%   
Return on assets %7.83.6 217.9%  
Return on equity %10.95.6 193.3%  
Return on capital %16.24.9 327.7%  
Exports to sales %51.30-   
Imports to sales %18.10-   
Net fx Rs m63,2790-   
CASH FLOW
From Operations Rs m35,703242,354 14.7%  
From Investments Rs m-22,660-85,876 26.4%  
From Financial Activity Rs m-298-290,720 0.1%  
Net Cashflow Rs m12,858-134,242 -9.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 74.87 Rs / USD

Compare DR. REDDYS LAB With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare DR. REDDYS LAB With: MEDICO REMEDIES   HINDUSTAN BIOSCIE  CIPLA  KERALA AYURV  PFIZER  



Today's Market

Sensex Trades Higher, Nifty Above 17,250; Power Grid, IOC & Titan Among Top Gainers(10:30 am)

Asian share markets fell in early trade today hit by worries about the Omicron coronavirus variant and a hawkish tilt at the US Federal Reserve.

Related Views On News

Dr Reddy's New Covid-19 Treatment Option Puts Stock in Focus (Views On News)

May 24, 2021

With the second wave pushing up sales of medicines, Indian pharma companies are likely to see traction in their volumes.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2022
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: How to Profit from Sensex 100,000
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

DR. REDDYS LAB SHARE PRICE


Dec 2, 2021 01:21 PM

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS